Kiljander, Toni
Helin, Timo
Venho, Kari
Jaakkola, Antero
Lehtimäki, Lauri
Article History
Received: 13 April 2015
Accepted: 1 June 2015
First Online: 16 July 2015
Competing interests
: TK received personal fees from Boehringer Ingelheim Finland, GSK, Novartis and Mundipharma. TH received personal fees from Boehringer Ingelheim Finland and Takeda. KV received personal fees from Boehringer Ingelheim Finland, Chiesi, GSK, Novartis, Takeda, Teva, Mundipharma and Almirall. AJ is an employee of Boehringer Ingelheim Finland. LL received personal fees from Almirall, Astra-Zeneca, Boehringer Ingelheim Finland, Chiesi, GSK, Novartis, Orion Pharma, Takeda and Mundipharma.